The rapid adoption of new technologies, such as Mobile, Internet of Things (IoT), Advanced Analytics or Cloud, is transforming businesses across industries – and will also impact healthcare significantly!
Blog
The rapid adoption of new technologies, such as Mobile, Internet of Things (IoT), Advanced Analytics or Cloud, is transforming businesses across industries – and will also impact healthcare significantly!
Over the next decade in healthcare we will see smartphones as hub of a “body area network”, integrating data, analysis, and real-time feedback to patients and caregivers. Another innovation will be sensors that are integrated into medical products and processes, linking patients and healthcare professionals (HCP), feeding insights to product development and marketing.
Based on our studies we haveidentified five technology-related trends that will lead to major disruptionsin the pharma and biotech industry by 2025:
To sum it up: Patient engagement capabilities are core to commercial models, competitors and non-traditional entrants seize control points, and the expectations on efficiency and agility will rise dramatically.
Based on these technology-related trends we see huge business opportunities within the pharma and biotech industry to drive value from digital:
Tailored care 24/7
By 2025 medication will be one element of a therapy that is customized based on many streams of data. How will it work? Body area networks containing sensors monitor and transmit physiological variables in real time to a cloud. If, for example, the glucose level decreases, a safety signal is triggered to the pharma company and recorded in the patient’s electronic health record (EHR). The safety signal is integrated with other wearables and EHR data by cloud analytics. A proactive alert is sent to the physician and the patient to prompt dose adjustment.
Automated processes
We also envision that by 2025 real-time automation is used to increase efficiency and introduce automation across processes. Supply chains will be highly automated with RFID-based tracking of relevant inputs and vendors. This leads to real-time resource planning, tracking and network optimization across manufacturing and distribution. Business support functions rely on automated digital workflows and better decision-support tools. Many in-house business applications are replaced by cloud-based services. In clinical trials, for instance, predictive analytics are widely adopted to optimize site, investigator and patient selection. Enrollment and dossier submission become entirely digital and cloud-based.
Digital is not only transforming patient care and existing business models – it will also revolutionize pharma operations and supply chains. The most important technologies we have identified are the Internet of Things (IoT) and Industry 4.0. And innovations have already started to impact the entire pharma value chain, from research & development, regulatory & safety to manufacturing, market access and commercialization. Pharma goes digital – and we are all part of it!
Comments
No comments